Literature DB >> 17059795

Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.

Karol Watson1.   

Abstract

The metabolic syndrome describes a clustering of risk factors that predispose individuals to cardiovascular disease and type 2 diabetes mellitus. Abdominal obesity is a key component of the metabolic syndrome, increasing the incidence of insulin resistance, vascular inflammation, dyslipidemia, and hypertension. Adipose tissue (now recognized as an endocrine organ) and its hormonal products appear to play a significant role in signaling organs throughout the body in the regulation of fat and glucose metabolism. These mechanisms are clearly involved in the development of cardiovascular and metabolic disease and may also lead to increased surgical risks. The components of the syndrome that are most likely to affect surgical patients are obesity, hypertension, and disorders of glucose metabolism. This article focuses on each of these risk factors, the effects on surgical patients, and strategies to improve outcomes in the perioperative period.

Entities:  

Mesh:

Year:  2006        PMID: 17059795     DOI: 10.1007/s11886-006-0101-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  41 in total

Review 1.  The prevention or delay of type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

Review 2.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

3.  ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-06-06       Impact factor: 24.094

4.  Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy.

Authors:  Matthew J McGirt; Graeme F Woodworth; Benjamin S Brooke; Alexander L Coon; Shamik Jain; Donald Buck; Judy Huang; Richard E Clatterbuck; Rafael J Tamargo; Bruce A Perler
Journal:  Neurosurgery       Date:  2006-06       Impact factor: 4.654

Review 5.  The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

Authors:  Stefan Engeli; Petra Schling; Kerstin Gorzelniak; Michael Boschmann; Jürgen Janke; Gérard Ailhaud; Michèle Teboul; Florence Massiéra; Arya M Sharma
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

6.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

7.  Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion.

Authors:  J D Sparks; C E Sparks
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

8.  Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group.

Authors:  A Wallace; B Layug; I Tateo; J Li; M Hollenberg; W Browner; D Miller; D T Mangano
Journal:  Anesthesiology       Date:  1998-01       Impact factor: 7.892

Review 9.  Lipid and non-lipid effects of statins.

Authors:  R Paoletti; C Bolego; A Cignarella
Journal:  Handb Exp Pharmacol       Date:  2005

10.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

View more
  2 in total

1.  Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes.

Authors:  Stavros G Memtsoudis; Meghan Kirksey; Yan Ma; Ya Lin Chiu; Madhu Mazumdar; Matthias Pumberger; Federico P Girardi
Journal:  Spine (Phila Pa 1976)       Date:  2012-05-15       Impact factor: 3.468

2.  Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion.

Authors:  Xiaoqi He; Qiaoman Fei; Tianwei Sun
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.